Pexidartinib




Pexidartinib Overview

Pexidartinib, sold under the brand name Turalio, is a kinase inhibitor drug for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.[2][3][4][5] On 2 August 2019, it was approved by U.S. FDA for treatment of giant-cell tumor of the tendon sheath (GC-TS).[2][6][7...

Read more Pexidartinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pexidartinib

Recent Pexidartinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pexidartinib
  • Capsule: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pexidartinib or a similar ingredient: (1 result)

  • TURALIO Pexidartinib Hydrochloride



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA